BNP Paribas Financial Markets’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-16
| Closed | -$204 | – | 3765 |
|
|
2019
Q4 | $204 | Sell |
16
-442
| -97% | -$5.64K | ﹤0.01% | 3636 |
|
|
2019
Q3 | $4.81K | Hold |
458
| – | – | ﹤0.01% | 3630 |
|
|
2019
Q2 | $7.79K | Sell |
458
-799
| -64% | -$13.6K | ﹤0.01% | 3531 |
|
|
2019
Q1 | $42.4K | Buy |
1,257
+555
| +79% | +$18.7K | ﹤0.01% | 3008 |
|
|
2018
Q4 | $20.5K | Sell |
702
-993
| -59% | -$29K | ﹤0.01% | 2438 |
|
|
2018
Q3 | $104K | Hold |
1,695
| – | – | ﹤0.01% | 2069 |
|
|
2018
Q2 | $125K | Buy |
1,695
+1,047
| +162% | +$77.3K | ﹤0.01% | 2045 |
|
|
2018
Q1 | $42.5K | Buy |
648
+27
| +4% | +$1.77K | ﹤0.01% | 3062 |
|
|
2017
Q4 | $52.2K | Buy |
621
+358
| +136% | +$30.1K | ﹤0.01% | 2979 |
|
|
2017
Q3 | $30.4K | Hold |
263
| – | – | ﹤0.01% | 2901 |
|
|
2017
Q2 | $30.7K | Buy |
263
+262
| +26,200% | +$30.6K | ﹤0.01% | 2927 |
|
|
2017
Q1 | $123 | Sell |
1
-34
| -97% | -$4.18K | ﹤0.01% | 3399 |
|
|
2016
Q4 | $4.81K | Sell |
35
-110
| -76% | -$15.1K | ﹤0.01% | 3127 |
|
|
2016
Q3 | $28.9K | Buy |
145
+60
| +71% | +$12K | ﹤0.01% | 2694 |
|
|
2016
Q2 | $11K | Buy |
+85
| New | +$11K | ﹤0.01% | 2870 |
|
|
2016
Q1 | – | Sell |
-165
| Closed | -$33.4K | – | 3181 |
|
|
2015
Q4 | $33.4K | Sell |
165
-22
| -12% | -$4.46K | ﹤0.01% | 3069 |
|
|
2015
Q3 | $27.2K | Buy |
187
+118
| +171% | +$17.1K | ﹤0.01% | 3205 |
|
|
2015
Q2 | $14.6K | Buy |
69
+49
| +245% | +$10.4K | ﹤0.01% | 3225 |
|
|
2015
Q1 | $4.63K | Buy |
+20
| New | +$4.63K | ﹤0.01% | 3201 |
|